Skip to main content
HELE logo

HELE · Helen Of Troy Ltd

Track HELE — free
$30.22 +0.22 (+0.73%) At close · Aug 14
Market Cap
$703.89M
Shares
23.29M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$30.22 Open$29.87 Day$29.53–30.39 52W close$13.88–30.22 Avg vol 30d499K Short int2.8M · 11.9% float · 6.7d Short vol55% Last earningsJul 8, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 8

Up next

Next earnings call
Oct 7, 2026 Est · unconfirmed · in 8 wks
FQ2-27 quarter ends
~Aug 28, 2026 Est
filed Jul 8, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +40%
      above
      Price vs 50-day avg +8%
      above
      RSI (14) 59
      neutral
      MACD trend Positive
      52-week position 100%
      near high
      Volume (OBV) Bearish div.
      distributing
      Momentum
      relative strength
      Very Strong
      1-month return +8%
      trailing
      6-month return +74%
      trailing
      YTD return +42%
      this year
      Relative strength +60%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $28 › 200d $22 — 50d above 200d
      Institutional flow Accumulating
      +5% holders QoQ · +47 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      11.92% of float · ▲ +2.9% MoM · 6.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      200 holders — mid 3-yr range
      Squeeze score 82
      high risk · 0–100
      Fundamentals
      Fair
      Revenue growth +6%
      Y/Y
      Gross margin 55%
      contracting
      EPS growth −828%
      Y/Y
      Buyback $496.8M
      remaining
      Balance sheet $761.9M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 60%
      annualized · 1-yr
      Max drawdown −50%
      past year
      ATR 4.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 3
      Latest guidance · from the 8-K filed Jan 8, 2026
      Home & Outdoor net sales · fiscal year 2026 Initiated $812M – $819M
      Beauty & Wellness net sales · fiscal year 2026 Initiated $946M – $954M
      Adjusted Diluted EPS · fiscal year 2026 Non-GAAP Initiated $3.25 – $3.75
      Consolidated net sales revenue · fiscal year 2026 Initiated $1.76B – $1.77B
      prior FY $1.79B midpoint −1.2% Y/Y
      Olive & June incremental net sales contribution · fiscal year 2026 Initiated $106M – $109M
      Interest expense · fiscal year 2026 Initiated $58M – $59M
      Adjusted effective tax rate · fiscal year 2026 Non-GAAP Initiated 13.4% – 14.7%
      Prior guidance period ended · from the Earnings Call filed May 31, 2024
      Net sales · fiscal '25 $1.89B – $1.94B
      Home and outdoor net sales · fiscal '25 -3% – -1%
      GAAP diluted EPS · fiscal '25 $4.69 – $5.45
      Beauty and wellness net sales · fiscal '25 -8% – -5%
      Adjusted EBITDA margin compression year-over-year · fiscal '25 -160% – -150%
      GAAP effective tax rate · fiscal '25 27.3% – 29.5%
      Non-GAAP adjusted diluted EPS · fiscal '25 $7.00 – $7.50
      Non-GAAP adjusted tax rate · fiscal '25 20.7% – 21.3%
      Capital and intangible asset expenditures · fiscal '25 $30M – $35M
      Guided vs delivered · last 3 settled
      Consolidated net sales revenue fiscal year 2026
      guided $1.76B – $1.77B
      $1.79B Beat +1.2%
      Net sales fiscal '25
      guided $1.97B – $2.03B
      $1.91B Miss −4.4%
      GAAP diluted EPS fiscal '25
      guided $6.68 – $7.45
      $5.37 Miss −24.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +40% Bullish
      Price vs 50-day avg
      +8% Bullish
      RSI (14)
      59 Neutral
      MACD trend
      Positive Bullish
      52-week position
      100% Bullish
      Volume (OBV)
      Bearish div. Bearish
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $28 › 200d $22 — 50d above 200d
      Institutional flow Accumulating
      +5% holders QoQ · +47 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      11.92% of float · ▲ +2.9% MoM · 6.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      200 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $14 Now $30 · 100% Range high $30
      vs 200-day avg +40% vs 50-day avg +8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP $190M Fiscal 2027 Outlook
      Free Cash Flow non-GAAP $85M Fiscal 2027 Outlook
      Beauty & Wellness net sales growth -0.5% Third Quarter Fiscal 2026
      Beauty & Wellness Organic business growth non-GAAP -13.9% Third Quarter Fiscal 2026
      Home & Outdoor net sales growth -6.7% Third Quarter Fiscal 2026
      Home & Outdoor Organic business growth non-GAAP -7.1% Third Quarter Fiscal 2026
      Net cash provided by operating activities $11.9M Third Quarter Fiscal 2026
      Non-GAAP adjusted diluted EPS non-GAAP $1.71 Third Quarter Fiscal 2026
      Non-GAAP adjusted EBITDA margin non-GAAP 14.7% Third Quarter Fiscal 2026
      Non-GAAP adjusted operating margin non-GAAP 12.9% Third Quarter Fiscal 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Household & Personal Products — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HELE
      Helen Of Troy Ltd
      this stock
      $703.89M +42.2% +5.8% 11.9%
      PG
      PROCTER & GAMBLE Co
      $336.00B +0.9% +3.3% 21.8 1.2%
      UL
      Unilever PLC
      $132.90B -5.1% 0.1%
      CL
      Colgate Palmolive Co
      $73.30B +16.4% +1.7% 36.3 2.2%
      RBGLY
      Reckitt Benckiser Group PLC
      $44.32B 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      200
      % held
      103.3%
      Net QoQ
      +1.7M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      74
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      2.8M
      Days to cover
      6.7d
      Change
      +78.2K sh
      View
      Short Volume
      Short vol %
      55%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      40
      Value
      $1.1K
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      40.6%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Josh Gottheimer
      Amount
      $1.0K–$15.0K
      Traded
      Jul 12, 2024
      View
      Financials
      Financials
      Revenue (FY)
      $1.8B
      Net income (FY)
      $-899.0M
      EPS diluted
      $-39.08
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $496.8M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 8, 2026
      This year
      9
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Aug 25, 2026
      Last call
      Jul 8, 2026
      View
      Investor Relations
      Latest news
      Helen of Troy Reports First Quart…
      Published
      Jul 8, 2026
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      HELE +1.5% +7.5% +73.8% +9.4% +42.2%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +1.1% +3.1% +60.0% +5.5% +28.4%

      Capital returns

      Buyback program · as of May 31, 2026
      Authorized
      $500.00M
      Spent (derived)
      $3.20M
      Remaining
      $496.80M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 916789 CUSIP G4388N106 13F (30d) 219 filings 193 filers Visit website Investor relations